Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Antibody Services Market by Type (Monoclonal, Polyclonal, Others, Antibody Service), By Application (BioScience Companies, BioScience Research Institutions, Hospitals, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Antibody Services Market by Type (Monoclonal, Polyclonal, Others, Antibody Service), By Application (BioScience Companies, BioScience Research Institutions, Hospitals, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 172002 3300 IT & Telecom 377 243 Pages 5 (40)
                                          

Market Overview:


The global antibody services market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for monoclonal antibodies and polyclonal antibodies, rising prevalence of chronic diseases, and growing number of biotechnology and pharmaceutical companies. The global antibody services market is segmented on the basis of type into monoclonal antibodies, polyclonal antibodies, and others. Monoclonal antibodies are expected to account for the largest share in this market due to their high specificity and affinity towards antigens. Polyclonal antibodies are also expected to witness significant growth during the forecast period due to their low cost as compared to monoclonal antibodies and increasing use in research applications. On the basis of application, this market is segmented into bioScience companies, bioScience research institutions, hospitals, other end users such as contract research organizations (CROs) and clinical trial centers), etc. BioScience companies are expected to account for the largest share in this market owingto their need for large quantities of high-quality custom-made monoclonal or polyclonal antibody products across all stages of drug development from discovery through commercialization.


Global Antibody Services Industry Outlook


Product Definition:


The term "antibody services" generally refers to the process of producing custom antibodies for research or diagnostic use. Antibodies are proteins that are produced by the body's immune system in response to foreign invaders, such as bacteria or viruses. They can be used to detect and identify these invaders, as well as other molecules related to disease.


Monoclonal:


Monoclonal antibodies are a specific type of antibody. They are produced by the B cell (B lymphocytes) in response to antigen. The B cells travel from the bone marrow to enter the blood stream and then attack and destroy germs or cancerous cells with high efficiency.


The most common types of cancers that develop into metastatic tumors which can then spread to other organs include breast cancer, lung cancer, skin melanoma, prostate carcinoma & liver carcinoma among others.


Polyclonal:


Polyclonal antibodies are made by the immune system and they are responsible for recognizing and binding to one specific antigen. They occur in two types, natural or human type, which is produced by the body's immune system and synthetic or laboratory manufactured type. Polyclonal antibodies can recognize multiple antigens on a single molecule however; they cannot distinguish between similar molecules such as that of an identical protein.


Application Insights:


The market is segmented by application into bio-science companies, bio-science research institutions, hospitals and others. The hospitals segment dominated the global market in 2017 owing to factors such as increasing prevalence of infectious diseases and rising healthcare expenditure. Antibody services are used for treatment of various autoimmune disorders at this level as well.


Bio-science companies were the largest revenue generating centers in 2017 due to high usage rates of antibodies in drug discovery and development processes across various industries such as food & beverage, diagnostics/labelling etc. Increasing R&D activities pertaining to biologics production have resulted in growth of this industry over the past few years which is expected to continue through 2030 with a CAGR around 11% from 2018 to 2030.


Regional Analysis:


North America dominated the global market in 2017. The presence of a large number of biotechnology and biopharmaceutical companies, which are engaged in drug discovery and development, has resulted in the high demand for antibodies services. In addition, increasing government funding for R&D activities pertaining to immunology-based research is expected to fuel the growth over the forecast period.


Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure coupled with rising investments by international players aimed at capitalizing on this opportunity. Moreover, an increase in disease prevalence levels due to urbanization and changing lifestyle habits will boost revenue generation from 2018 to 2030  in this region.


Growth Factors:


  • Increasing demand for monoclonal antibodies for therapeutic and diagnostic applications
  • Growing prevalence of cancer and other chronic diseases
  • Rising investments in life sciences sector
  • Proliferation of biotechnology and pharmaceutical companies
  • Technological advancements in antibody production

Scope Of The Report

Report Attributes

Report Details

Report Title

Antibody Services Market Research Report

By Type

Monoclonal, Polyclonal, Others, Antibody Service

By Application

BioScience Companies, BioScience Research Institutions, Hospitals, Other

By Companies

ThermoFisher, GenScript, Abcam, MBS, ROCKLAND, ProSci, Anaspec, Bio-Rad, Covance, Capra Science, Innovagen, APS, Randox, GL Biochem, Abgent, Antibody Service

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

243

Number of Tables & Figures

171

Customization Available

Yes, the report can be customized as per your need.


Global Antibody Services Market Report Segments:

The global Antibody Services market is segmented on the basis of:

Types

Monoclonal, Polyclonal, Others, Antibody Service

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

BioScience Companies, BioScience Research Institutions, Hospitals, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. ThermoFisher
  2. GenScript
  3. Abcam
  4. MBS
  5. ROCKLAND
  6. ProSci
  7. Anaspec
  8. Bio-Rad
  9. Covance
  10. Capra Science
  11. Innovagen
  12. APS
  13. Randox
  14. GL Biochem
  15. Abgent
  16. Antibody Service

Global Antibody Services Market Overview


Highlights of The Antibody Services Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Monoclonal
    2. Polyclonal
    3. Others
    4. Antibody Service
  1. By Application:

    1. BioScience Companies
    2. BioScience Research Institutions
    3. Hospitals
    4. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Antibody Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Antibody Services Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Antibody Services is a company that provides antibody testing and other immunology services.

Some of the major players in the antibody services market are ThermoFisher, GenScript, Abcam, MBS, ROCKLAND, ProSci, Anaspec, Bio-Rad, Covance, Capra Science, Innovagen, APS, Randox, GL Biochem, Abgent, Antibody Service.

The antibody services market is expected to register a CAGR of 10.8%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Antibody Services Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Antibody Services Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Antibody Services Market - Supply Chain
   4.5. Global Antibody Services Market Forecast
      4.5.1. Antibody Services Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Antibody Services Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Antibody Services Market Absolute $ Opportunity

5. Global Antibody Services Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Antibody Services Market Size and Volume Forecast by Type
      5.3.1. Monoclonal
      5.3.2. Polyclonal
      5.3.3. Others
      5.3.4. Antibody Service
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Antibody Services Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Antibody Services Market Size and Volume Forecast by Application
      6.3.1. BioScience Companies
      6.3.2. BioScience Research Institutions
      6.3.3. Hospitals
      6.3.4. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Antibody Services Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Antibody Services Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Antibody Services Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Antibody Services Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Antibody Services Demand Share Forecast, 2019-2026

9. North America Antibody Services Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Antibody Services Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Antibody Services Market Size and Volume Forecast by Application
      9.4.1. BioScience Companies
      9.4.2. BioScience Research Institutions
      9.4.3. Hospitals
      9.4.4. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Antibody Services Market Size and Volume Forecast by Type
      9.7.1. Monoclonal
      9.7.2. Polyclonal
      9.7.3. Others
      9.7.4. Antibody Service
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Antibody Services Demand Share Forecast, 2019-2026

10. Latin America Antibody Services Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Antibody Services Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Antibody Services Market Size and Volume Forecast by Application
      10.4.1. BioScience Companies
      10.4.2. BioScience Research Institutions
      10.4.3. Hospitals
      10.4.4. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Antibody Services Market Size and Volume Forecast by Type
      10.7.1. Monoclonal
      10.7.2. Polyclonal
      10.7.3. Others
      10.7.4. Antibody Service
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Antibody Services Demand Share Forecast, 2019-2026

11. Europe Antibody Services Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Antibody Services Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Antibody Services Market Size and Volume Forecast by Application
      11.4.1. BioScience Companies
      11.4.2. BioScience Research Institutions
      11.4.3. Hospitals
      11.4.4. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Antibody Services Market Size and Volume Forecast by Type
      11.7.1. Monoclonal
      11.7.2. Polyclonal
      11.7.3. Others
      11.7.4. Antibody Service
   11.8. Basi Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Antibody Services Demand Share, 2019-2026

12. Asia Pacific Antibody Services Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Antibody Services Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Antibody Services Market Size and Volume Forecast by Application
      12.4.1. BioScience Companies
      12.4.2. BioScience Research Institutions
      12.4.3. Hospitals
      12.4.4. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Antibody Services Market Size and Volume Forecast by Type
      12.7.1. Monoclonal
      12.7.2. Polyclonal
      12.7.3. Others
      12.7.4. Antibody Service
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Antibody Services Demand Share, 2019-2026

13. Middle East & Africa Antibody Services Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Antibody Services Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Antibody Services Market Size and Volume Forecast by Application
      13.4.1. BioScience Companies
      13.4.2. BioScience Research Institutions
      13.4.3. Hospitals
      13.4.4. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Antibody Services Market Size and Volume Forecast by Type
      13.7.1. Monoclonal
      13.7.2. Polyclonal
      13.7.3. Others
      13.7.4. Antibody Service
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Antibody Services Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Antibody Services Market: Market Share Analysis
   14.2. Antibody Services Distributors and Customers
   14.3. Antibody Services Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. ThermoFisher
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. GenScript
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Abcam
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. MBS
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. ROCKLAND
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. ProSci
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Anaspec
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Bio-Rad
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Covance
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Capra Science
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Innovagen
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. APS
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Randox
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. GL Biochem
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. Abgent
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. Antibody Service
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us